Q&A library
Long-tail life sciences insurance questions, answered in depth.
Detailed answers to the specific questions life-sciences operators ask before signing a sponsor MSA, registering as a 503B, joining a GPO, or onboarding a new sponsor relationship. Each entry is a full-page treatment of one question.
Question
What is clinical laboratory professional liability insurance and what does it actually cover?
Entity-level professional liability for a clinical laboratory: what triggers a claim, how it differs from an individual pathologist’s malpractice policy, why the claims-made retroactive date matters more than the limit, and what drives the price.
Read the full answer →
Question
How does workers compensation handle a needlestick or sharps injury in a laboratory?
Needlestick and bloodborne pathogen exposure in a lab: what workers compensation pays for, why the post-exposure follow-up rather than the wound is the real cost, and how OSHA’s Bloodborne Pathogens Standard shapes underwriting.
Read the full answer →
Question
What insurance does a small medical device company need?
The coverage a small or early-stage medical device company actually needs, sequenced by stage: what to buy before clearance, what changes at first commercial sale, and which lines a generic small-business policy leaves out.
Read the full answer →
Question
What insurance covers laboratory billing and coding errors, payor audits, and False Claims Act exposure?
Billing errors and payor audits are a distinct laboratory exposure that general liability and standard professional liability usually do not address. What responds, what does not, and how automated coding tools change the analysis.
Read the full answer →
Question
Does cyber insurance respond to an OCR HIPAA enforcement action when there was no breach?
HHS Office for Civil Rights penalises documentation and risk-analysis failures with no breach involved. Whether a breach-triggered cyber policy attaches to that is a question worth resolving before it is tested.
Read the full answer →
Question
Does a laboratory’s insurance automatically cover new tests added to the menu?
Adding assays, bringing a send-out in house, or launching a laboratory developed test changes the risk the policy was underwritten against. When that becomes a notification duty rather than a renewal footnote.
Read the full answer →
Question
Does products liability cover a device version created by a post-market software or AI model update?
When harm comes from a software release or a retrained model rather than the version that was cleared and shipped, the coverage question is which policy period and which product the claim attaches to.
Read the full answer →
Question
What should a laboratory check on the certificates of insurance it receives from couriers and vendors?
Most guidance covers producing a certificate. This covers reviewing one: what a certificate does and does not prove, and the specific wording to require from couriers, phlebotomy contractors, and waste handlers.
Read the full answer →
Question
Is the referring laboratory still liable when it sends a test out to a reference lab?
Sending a specimen to a reference laboratory does not transfer the relationship with the patient or the ordering clinician. How liability and professional liability coverage actually sit when the work was performed elsewhere.
Read the full answer →
Question
Does a US medical device liability policy cover claims from international sales?
Standard US products liability forms extend worldwide to products made or sold in the US, but usually only when liability is decided in a US or Canadian suit. What that proviso means when you sign your first international distribution agreement.
Read the full answer →
Question
Does EU MDR compliance extend a US device maker’s products liability to EU claims?
What the EU Medical Device Regulation actually requires on financial coverage, how the EU Authorised Representative becomes a liability channel back to a US manufacturer, and why the revised Product Liability Directive matters before December 2026.
Read the full answer →
Question
What is a controlled master program with difference in conditions coverage, and when does a life sciences company need one?
How locally admitted policies, a master policy, and difference in conditions and difference in limits coverage fit together once a life sciences company has foreign entities, staff, or manufacturing.
Read the full answer →
Question
Does a US cyber policy respond when a digital health platform onboards EU or UK users?
Cyber and technology E&O forms are often worldwide for the core insuring agreements, but regulatory defense and penalties is the section that varies by jurisdiction. What changes the day non-US users can sign up.
Read the full answer →
Question
What insurance does a US lab need to receive specimens from outside the United States?
Coverage territory for laboratory professional liability, foreign collection sites as subcontractors, import permit obligations, and transit exposure when specimens cross a border.
Read the full answer →
Question
How fast can you get a certificate of insurance for a contract, and what does it cost?
How quickly a certificate of insurance (COI) can be issued to satisfy a contract, what actually causes the delays (endorsement wording, not the certificate itself), and how the cost breaks down.
Read the full answer →
Question
What if you cannot meet the insurance requirements in a contract?
A practical path when a contract asks for insurance you do not have: separate quick endorsement fixes from real coverage gaps, put the achievable coverage in place, and negotiate the boilerplate the counterparty will usually adjust.
Read the full answer →
Question
What insurance do you need to sign a partnership or vendor agreement in life sciences?
Partnership, vendor, and platform agreements typically require general liability, products liability, and cyber liability at set limits, plus additional-insured and primary and non-contributory wording. What the insurance exhibit asks for and how to satisfy it the first time.
Read the full answer →
Question
What insurance do you need to partner with or resell a telehealth company's services?
Companies marketing or reselling another telehealth provider's services are typically required to carry general liability, products liability, and cyber liability with HIPAA coverage, and to name the telehealth partner as additional insured. What the requirement looks like and how to meet it.
Read the full answer →
Question
Does a 503B outsourcing facility need dedicated product recall coverage?
Why FDA-recall extensions on standard products liability policies are typically insufficient for 503B outsourcing facilities, and what dedicated recall coverage looks like.
Read the full answer →
Question
Which MSA clauses require additional insured status for products and completed operations?
How sponsor MSAs require additional insured for products and completed operations, why blanket AI endorsements often exclude it, and what ISO CG 20 37 looks like in practice.
Read the full answer →
Question
Does clinical trial liability insurance cover investigator-sponsors and clinical sites?
How clinical trial liability policies handle investigator-sponsor coverage, what sponsor IND-holder responsibilities look like for insurance, and where CROs sit in the structure.
Read the full answer →
Question
How does USP 797 / 800 compliance compare to FDA cGMP for insurance underwriting?
USP 797 and USP 800 vs FDA cGMP - which standard applies to which compounder, how insurance carriers underwrite each, and what compliance documentation matters at renewal.
Read the full answer →
Question
What insurance options do GLP-1 compounding pharmacies have right now?
The GLP-1 compounding insurance landscape - carrier exclusions, products liability availability, druggist PL options, and how 503A and 503B compounders are navigating the firestorm.
Read the full answer →
Question
What insurance coverage does a medical device manufacturer need to supply a GPO?
Group purchasing organization (GPO) supplier insurance requirements for medical device manufacturers - products liability limits, additional insured, hospital purchase contract pass-through, and credentialing platform enforcement.
Read the full answer →
Question
What insurance does PBM credentialing require for a pharmacy?
Pharmacy benefit manager (PBM) credentialing insurance requirements - druggist professional liability, products, cyber, HIPAA, and carrier rating. Why credentialing failure locks the pharmacy out of reimbursement.
Read the full answer →
Question
Does a 503A compounding pharmacy actually need products liability insurance?
When 503A compounding pharmacies need products liability coverage, why druggist professional liability alone is insufficient at scale, and how PBM credentialing and accreditation interact with products coverage.
Read the full answer →
Question
How much cyber liability does a CRO handling PHI typically carry?
Cyber liability sizing for CROs handling protected health information - limits by subject count, PHI sensitivity, and sponsor-required minimums. HIPAA breach response, regulatory defense, and ransomware coverage.
Read the full answer →
Question
How do I evaluate the insurance section of a sponsor MSA before signing?
A practical walkthrough for life-sciences operators reviewing the insurance schedule of a sponsor master services agreement - what to look for, what to push back on, and how to identify hidden compliance traps.
Read the full answer →
Question
Does a pre-revenue clinical-stage biotech need D&O insurance?
Why pre-revenue clinical-stage biotechs typically need D&O coverage despite having no commercial product - investor disputes, regulatory investigations, employment claims, and Side A protection.
Read the full answer →
Question
Where do CDMOs and CROs have leverage to negotiate sponsor MSA insurance terms?
A practical map of which sponsor MSA insurance terms are negotiable versus universally enforced - limits, AI wording, indemnity, survival, and form requirements.
Read the full answer →
Question
How does CDMO claims history affect insurance renewal pricing?
How insurance carriers underwrite CDMO renewals based on prior claims experience, what counts as a "clean" history, and how operators can mitigate the impact of prior claims at renewal.
Read the full answer →
Question
How much does life sciences insurance cost by company revenue?
Typical Texas life-sciences insurance premium ranges by company revenue band and sub-vertical - CDMO, CRO, medical device, biotech, compounding pharmacy, 503B outsourcing.
Read the full answer →
Question
What insurance does a clinical lab need for laboratory-developed tests (LDTs)?
Insurance for clinical and diagnostic labs running laboratory-developed tests (LDTs) - products liability with LDT extensions, professional liability for diagnostic accuracy, cyber/HIPAA, and the regulatory landscape after the FDA LDT rule vacatur.
Read the full answer →
Question
What insurance does a biotech spinout from an academic institution need?
Insurance considerations for biotech spinouts from academic medical centers and universities - IP/license-back implications, IIS coverage, D&O sized to early-stage governance, shared facilities, and the typical Series A program shape.
Read the full answer →
Question
What cyber insurance do biotechs need for IPO readiness?
How clinical-stage biotechs approaching IPO should size cyber and information-security insurance - disclosure obligations, SEC cyber rules, EDGAR cyber incident reporting, and the interaction with D&O securities exposure.
Read the full answer →
Question
How do you structure insurance for a multi-site CDMO acquisition?
Insurance considerations for CDMO M&A - representations and warranties insurance, tail coverage on target programs, integration of new facilities into existing property and products policies, and the timeline from LOI through close.
Read the full answer →
Question
How much does a sponsor MSA insurance review cost?
Typical cost ranges for sponsor MSA insurance reviews by life-sciences brokers and specialty counsel - what the review covers, when to engage outside review, and the cost vs benefit calculation.
Read the full answer →
Question
How does workers compensation work for biotech research staff?
Workers compensation considerations for biotech and pharma research operations - class codes for laboratory and clinical staff, BSL-2/3/4 lab environment effects, and how biotech-specific exposures (chemical, biological, radiation) factor into WC underwriting.
Read the full answer →
Question
How does workers compensation work for CRO and clinical research staff?
Workers compensation for contract research organizations - class codes for clinical monitors, CRAs, central lab and bioanalytical staff, the travel exposure that defines CRO WC, foreign voluntary WC for ex-US trials, and sponsor MSA statutory requirements.
Read the full answer →
Question
How does workers compensation work for compounding pharmacy staff?
Workers compensation for 503A and 503B compounding pharmacies - pharmacy class codes, USP 800 hazardous drug exposure, sterile compounding injury risk, how 503B operators classify closer to drug manufacturing, and Texas non-subscriber issues.
Read the full answer →
Question
How does workers compensation work for medical device manufacturers?
Workers compensation for medical device manufacturers - how class codes follow the actual production process (cleanroom assembly, machining, sterilization), ethylene oxide and chemical exposure, GPO and hospital supplier statutory WC requirements, and premium drivers.
Read the full answer →
Question
What workers compensation class codes apply to life sciences and laboratory staff?
Workers compensation class codes for life sciences and laboratory staff - analytical and chemical laboratory codes, drug research classifications, clerical and outside codes, how NCCI states differ from California (WCIRB) and other independent states, and misclassification audit risk.
Read the full answer →
Question
What does USP 800 require for compounding pharmacies, and how does it affect insurance?
USP General Chapter 800 requirements for hazardous drug handling at compounding pharmacies - containment engineering controls, PPE, environmental monitoring, medical surveillance - and how USP 800 compliance affects workers compensation, products liability, druggist professional liability, and carrier appetite.
Read the full answer →
Question
Does a 503B outsourcing facility need Joint Commission certification?
Whether a 503B outsourcing facility needs Joint Commission Medication Compounding Certification (MCC) - legal requirement versus hospital-purchaser expectation, the insurance underwriting credit it provides, how it relates to FDA cGMP, and when it is worth pursuing.
Read the full answer →
Question
How do USP 797 inspection findings affect compounding pharmacy insurance?
How state board and USP 797 inspection observations affect compounding pharmacy insurance - why inspection history drives underwriting, the impact of the 2023 USP 797 revision, what carriers request at renewal, the cost of material findings, and how to build a favorable profile.
Read the full answer →
Question
How much umbrella (excess) liability does a life sciences company need?
How to size umbrella and excess liability for life sciences operators - CDMOs, CROs, biotech, medical device, 503B - against sponsor MSA, GPO, and hospital purchase contract total-limit requirements, what the umbrella does and does not cover, and typical limit bands.
Read the full answer →
Question
What is the difference between umbrella and excess liability for life sciences operators?
Umbrella vs excess liability for life sciences operators - how umbrella can drop down to fill gaps while follow-form excess only adds limits over a scheduled underlying policy, and why the distinction matters most for the products and completed operations tower.
Read the full answer →
Question
What umbrella or excess limits do sponsor MSAs and hospital contracts require?
What total liability limits pharmaceutical sponsor MSAs, GPO supplier agreements, and hospital purchase contracts require from life sciences operators - typical bands by segment, how the umbrella must extend additional insured up the tower, and how it shows on the certificate of insurance.
Read the full answer →
Question
Does property insurance cover validation losses at cGMP facilities?
How property insurance covers cGMP facility losses including batch and validation losses - drug-manufacturer property forms, cleanroom contamination, HVAC and environmental excursions, and the gap left by generic commercial property policies.
Read the full answer →
Question
Do pharmaceutical and biotech operators need environmental impairment liability insurance?
When pharma manufacturers, biotech operators, 503B outsourcing facilities, and contract testing labs need standalone environmental impairment liability (EIL) coverage - pollution exposures, solvent and API handling, radiopharmaceutical and biohazard scenarios.
Read the full answer →
Question
Can a CDMO share insurance with its sponsor under the MSA?
Whether CDMOs and pharma sponsors can share insurance programs under a master services agreement - the legal and practical limits, OCIP/CCIP structures, and why standalone CDMO programs remain standard.
Read the full answer →
Question
What insurance does a biotech IPO actually require?
The four insurance programs a clinical-stage biotech needs in place before an IPO or SPAC merger - transactional D&O, run-off D&O for the pre-IPO entity, EPLI sized to the new headcount profile, cyber for the new disclosure obligations - and the timing.
Read the full answer →
Question
How much does products liability insurance cost for a CDMO with $20M revenue?
Typical products liability premium ranges for a Texas pharma CDMO at $20M revenue - by product class, sponsor mix, and tower structure. What drives the spread, the gap between admitted and surplus-lines pricing, and where the unexpected costs live.
Read the full answer →
Question
What's the difference between products liability and product recall coverage?
Products liability covers third-party injury from a defective product; product recall coverage covers the first-party cost of executing the recall. The key differences.
Read the full answer →
Question
What insurance does a digital health / AI healthtech startup need before fundraising?
Digital health and AI healthtech startups face a different insurance profile than biotech or medical device - Tech E&O sized to enterprise SaaS terms, cyber sized to PHI/PHR volume, D&O at term sheet, and possibly clinical decision support liability depending on FDA classification.
Read the full answer →
Question
Can a 503A compounding pharmacy operate without products liability insurance?
A 503A pharmacy can technically operate without products liability since state law and PBM contracts typically require only druggist professional liability - but it is structurally exposed to patient injury claims that PL does not cover. The risk math rarely favors going without.
Read the full answer →
Question
What insurance does a medical device company need around 510(k) clearance?
Insurance program structure for medical device companies going through 510(k) clearance - products liability sizing at clearance vs at commercial launch, clinical trial liability for premarket studies, recall coverage architecture, D&O for VC-backed device startups.
Read the full answer →
Question
What insurance does a Software as a Medical Device (SaMD) company need?
SaMD companies face a double-coverage requirement - Tech E&O for the software dimension and products liability for the FDA-regulated medical device dimension. Coverage overlap, gap zones, and how AI-driven SaMD changes the underwriting question.
Read the full answer →
Question
What insurance does a CLIA-certified clinical laboratory need?
CLIA-certified clinical and molecular laboratories need professional liability for testing accuracy claims, cyber sized to PHI volume, products liability for any laboratory-developed tests (LDTs), and property programs that cover specialized instruments - plus E&O for any clinical advisory or interpretation services.
Read the full answer →
Question
What is the cheapest insurance program a pre-seed biotech startup needs to operate legally?
Minimum viable insurance for a pre-seed biotech startup - what you legally and contractually need versus what you can defer until Series A.
Read the full answer →
Question
Does the Texas LLC structure matter for life sciences insurance underwriting?
How Texas LLC, series LLC, and multi-entity structures affect life sciences insurance program design - named-insured wording, additional-insured passthroughs, and per-entity vs blanket policies.
Read the full answer →
Question
What is the difference between fiduciary liability and D&O insurance for a biotech with employee benefit plans?
Fiduciary liability covers ERISA breach-of-fiduciary-duty claims arising from employee benefit plan administration; D&O covers management decisions. The two coverages do not overlap and biotechs need both once they sponsor a 401(k) or similar plan.
Read the full answer →
Question
What insurance does an AI drug discovery startup need?
AI drug discovery startups operate at the intersection of biotech, SaaS, and AI/ML risk - the program combines tech E&O, cyber, D&O, IP infringement, and where the platform produces clinical decision support, SaMD-classification considerations.
Read the full answer →
Question
When does a biotech consider a captive insurance company versus a group captive?
Captive insurance companies become economically rational for biotechs at meaningful self-insurance retention size - typically $5M+ annual premium across the program. Group captives lower the threshold by aggregating multiple insureds.
Read the full answer →
Question
When does a life sciences company need foreign voluntary workers compensation coverage?
Foreign voluntary workers compensation covers US employees traveling internationally for business - clinical trial monitoring, CRO oversight, manufacturing audits. Standard US workers comp policies do not respond to injuries occurring outside the United States.
Read the full answer →
Question
Does biotech insurance cover patent infringement claims?
Standard biotech insurance policies do not cover patent infringement claims as a default; explicit IP infringement coverage is purchased as a sub-limit on E&O, as part of tech E&O, or as a standalone IP defense policy.
Read the full answer →
Question
What is the insurance difference between a 503B outsourcing facility compounding GLP-1 and a 503A pharmacy compounding GLP-1?
A 503B outsourcing facility compounding GLP-1 faces FDA-registered manufacturer products liability underwriting and hospital purchase contract insurance schedules; a 503A pharmacy compounding GLP-1 faces druggist professional liability and pharmacy-scale products liability with the same GLP-1 carrier-exclusion crisis affecting both.
Read the full answer →
Question
Does biotech D&O coverage need to change for a bridge financing or convertible note round?
Bridge financings and convertible note rounds typically do not require D&O policy changes, but a few specific structural elements (most-favored-nation provisions, lead-investor board observer rights, pay-to-play features) can trigger D&O renewal questions and limit changes.
Read the full answer →
Question
Which sponsor MSA insurance requirements are typically negotiable versus immovable?
Sponsor MSA insurance requirements vary widely in negotiability - limits are typically immovable for major pharma sponsors, additional-insured wording often allows alternative endorsements, notice-of-cancellation language is sometimes negotiable to standard ISO wording, and aggregate-per-project endorsements are typically achievable.
Read the full answer →
Question
Can pharmaceutical companies be held liable for their products?
Yes - pharmaceutical companies face strict liability, negligence, failure-to-warn, and design-defect claims for drug and device products. What that means for insurance program structure.
Read the full answer →
Question
What does pharmaceutical products liability insurance not cover?
The most common exclusions on pharma and medical device products liability policies: known defects, withdrawn products, recall first-party costs, off-label, contractual liability assumed without endorsement, and more.
Read the full answer →
Question
Who needs pharmaceutical products liability insurance?
Every operator in the pharmaceutical supply chain that touches a drug or device - CDMOs, biotech, 503B outsourcing, compounding pharmacies, medical device manufacturers, CROs - needs products liability coverage scaled to contract demands.
Read the full answer →
Question
What is clinical trial liability insurance?
Clinical trial liability insurance covers bodily injury and death claims from human study subjects participating in pharmaceutical, biotech, and medical device trials. What it covers, who needs it, and typical limits.
Read the full answer →
Question
What is 503B compounding insurance?
503B compounding insurance is the specialized program required for FDA-registered outsourcing facilities - products liability, recall, druggist professional, hospital additional insured, and cGMP-specific endorsements.
Read the full answer →
Question
Is a 503B compounding pharmacy FDA-approved?
503B outsourcing facilities are FDA-registered and FDA-inspected but their compounded products are not individually FDA-approved. The distinction matters for insurance and contract obligations.
Read the full answer →
Question
What is safer, 503A or 503B?
503B facilities operate under cGMP and ongoing FDA inspection; 503A pharmacies operate under state board oversight and USP compounding standards. Each is safe for its intended use case. The insurance question turns on contractual demands, not relative safety.
Read the full answer →
Question
Why are compounding pharmacies being shut down - and what insurance covers it?
FDA enforcement, state pharmacy board action, and carrier exclusions are closing compounding pharmacies in 2025-2026. What's actually driving closures and what insurance can and cannot do.
Read the full answer →
Question
What are the risks of CDMO operation that drive insurance requirements?
CDMO insurance is shaped by five recurring operator-side risks: sponsor MSA scope creep, products liability tower adequacy, recall execution capability, validation/cGMP downtime, and IP/trade secret leakage.
Read the full answer →
Question
How does a CDMO ensure regulatory compliance under sponsor MSA insurance demands?
Sponsor MSA insurance demands and FDA cGMP compliance are different problems - insurance evidences compliance but does not cause it. The operator-side discipline that satisfies both.
Read the full answer →
Question
How much is small business insurance for life sciences?
Annual insurance premium ranges for small life sciences businesses ($1M-$10M revenue) by sub-vertical - CDMO, CRO, biotech, compounding pharmacy, 503B, medical device, diagnostic lab. The cost drivers that move premium materially.
Read the full answer →
Question
How much does clinical trial liability insurance cost?
Clinical trial liability insurance typically costs $15K-$50K per study for Phase 1, $50K-$150K for Phase 2/3 multi-site, and $200K+ for global Phase 3 with EU sites and cell/gene therapy indications.
Read the full answer →
Question
What is druggist professional liability?
Druggist professional liability is dedicated coverage for service-side errors in dispensing, compounding, mislabeling, or BUD miscalculation - the pharmacy-specific equivalent of professional liability for service errors.
Read the full answer →
Question
What insurance does a digital health startup need?
Digital health startups need technology E&O sized to platform scope, cyber for PHI handling under HIPAA, products liability if FDA-cleared as SaMD, D&O if VC/PE backed, and clinical trial liability if conducting prospective studies.
Read the full answer →
Question
Do compounding pharmacies need recall insurance?
503A traditional compounders rarely need dedicated recall coverage; 503B outsourcing facilities typically need it as a hospital purchase contract condition at $3M-$10M first-party limits.
Read the full answer →
Question
How does Symplr / Reptrax credentialing work for medical device suppliers?
Symplr (now Vendormate) and Reptrax are hospital-side credentialing platforms enforcing GPO supplier insurance schedules. Suppliers upload COIs and endorsements; missing or non-compliant coverage suspends purchasing.
Read the full answer →
Question
Are labs covered by insurance? (Lab insurance and laboratory coverage explained)
Yes - diagnostic, clinical, pathology, molecular, and bioanalytical labs are covered by specialty lab insurance built around cyber, professional liability for diagnostic accuracy, and hospital reference-lab service-agreement compliance. Not the same as generic small-business insurance.
Read the full answer →
Question
What is the average cost of a pharmaceutical product recall?
Average pharmaceutical product recall cost runs $10M-$30M for an FDA Class II event at a mid-market manufacturer. Class I recalls escalate to $50M-$600M+ given litigation. Notification, retrieval, replacement, destruction, lost profit, and downstream litigation all stack.
Read the full answer →
Question
How to get insurance to cover GLP-1 compounding (after the FDA enforcement wave)?
After the March 2026 FDA enforcement wave ended the GLP-1 shortage list, most generalist carriers added GLP-1 exclusions. Coverage is still available through specialty markets that require dose protocols, prescriber credentialing documentation, and adverse-event workflows in place.
Read the full answer →
Question
Do startup biotechs need products liability insurance?
No - pre-commercial startup biotechs do not need products liability until commercialization approaches. Pre-revenue clinical-stage biotechs need D&O, clinical trial liability, cyber, EPLI, and IP/E&O instead.
Read the full answer →
Question
What insurance does a SaMD (software-as-a-medical-device) operator need?
SaMD operators need cyber as the primary product-liability vehicle ($10M-$50M sized to patient impact), algorithm liability for AI/ML errors, HIPAA Business Associate scope, Tech E&O for non-product services, and SOC 2 Type II documentation.
Read the full answer →
Question
What is the insurance difference between FDA Class II and Class III medical devices?
FDA Class II (510(k)) devices need $5M-$15M products tower with MDR liability extension. Class III (PMA) implantables need $25M-$100M+ tower on occurrence form non-negotiable, with long-tail considerations driven by 10-20+ year claim windows on implants.
Read the full answer →
Question
Does the sponsor or the CRO pay for clinical trial insurance?
The sponsor pays for clinical trial liability (CTL) - the sponsor holds the IND, sets the protocol, and bears the regulatory subject-protection obligation. The CRO pays for professional liability and E&O sized to monitoring scope.
Read the full answer →
Question
What insurance does a biotech need before Series A?
Before Series A: D&O ($1M-$5M, mandatory at term sheet), basic CGL, workers comp, cyber for IND data and drug master file ($1M-$3M), employment practices once headcount exceeds 10. Add clinical trial liability when first-in-human dosing approaches.
Read the full answer →
Question
How does a typical sponsor MSA insurance schedule read?
A typical pharmaceutical sponsor MSA insurance schedule requires: occurrence-form CGL ($1M/$2M), products liability ($5M-$10M), professional liability/E&O, workers comp, cyber, additional insured (CG 20 10 + CG 20 37), primary and non-contributory, waiver of subrogation, 30-day notice of cancellation. Survival 7+ years post-termination.
Read the full answer →
Question
What cyber insurance does a clinical laboratory need?
Clinical labs need cyber sized to annual specimen volume and PHI sensitivity - NOT headcount or revenue. $5M-$25M typical for mid-size labs; high-volume hospital reference labs scale to $50M+. HIPAA breach response, ransomware operational interruption BI, state genetic privacy regulatory defense, and contingent LIS/middleware vendor coverage.
Read the full answer →
Question
Do compounding pharmacies need products liability insurance?
503A compounding pharmacies typically need $1M/$2M products liability as a secondary line beneath druggist professional liability. 503B outsourcing facilities operate as drug manufacturers and need $5M-$10M products as the primary line.
Read the full answer →
Question
What types of insurance does a small life sciences company need?
The core insurance lines a small biotech, CRO, CDMO, medical device, or compounding company needs: general liability, products/professional liability, D&O, clinical trial, property, workers comp, cyber, and umbrella - and how to sequence them by stage.
Read the full answer →
Question
How do you choose an insurance broker for a life sciences company?
What to look for in a life sciences insurance broker: specialty carrier access, MSA and contract-review capability, claims advocacy, program architecture across stages, and the questions that separate a specialist from a generalist.
Read the full answer →
Question
What products liability insurance do medical device manufacturers need?
How medical device manufacturers size products liability insurance by device class (FDA Class I/II/III), what GPO and hospital purchase contracts require, and why the products/completed-operations endorsement is the load-bearing piece.
Read the full answer →
Question
What types of insurance does a small clinical-trials company or CRO need?
The core insurance lines a small CRO or clinical-trials company needs: professional liability (E&O), clinical trial liability, general liability, D&O, cyber for trial data/PHI, workers comp, and umbrella - and how sponsor CTAs and MSAs drive the limits.
Read the full answer →
Question
What coverage limits does clinical trial liability insurance require?
How clinical trial liability insurance limits are set - by trial phase, indication, subject count, and geography - what sponsor CTAs and ethics committees typically require, and why per-subject and aggregate limits both matter.
Read the full answer →
Question
Does a life sciences company with employees need employment practices liability (EPLI) insurance?
Why life-sciences employers - biotech, CDMO, CRO, device, lab - carry employment practices liability (EPLI) for wrongful termination, discrimination, harassment, retaliation, and wage-and-hour claims, how it is bought (standalone, D&O endorsement, or BOP add-on), and typical limits and premium.
Read the full answer →
Question
Does a clinical-trials company or CRO need EPLI for its research staff?
Why CROs, clinical-trial sites, and research organizations carry employment practices liability (EPLI) for their monitors, coordinators, and scientists - the project-based hiring, multistate travel, and wage-and-hour misclassification exposures that make research staffing higher-risk - and how EPLI fits the CRO program.
Read the full answer →
Question
Does a biotech or life sciences startup need a business owners policy (BOP), and what does it actually cover?
What a business owners policy (BOP) is, what it covers and excludes for a biotech or life-sciences startup, why it is the right early-stage floor but not a complete program (it excludes products, professional/E&O, D&O, clinical trial, and cyber), and when a company outgrows it.
Read the full answer →
Question
Is a business owners policy (BOP) enough for a clinical-trials company or CRO?
Why a business owners policy (BOP) is only the floor for a clinical-trials company or CRO - it bundles general liability and property but leaves out the three lines that define research risk: professional liability (E&O), clinical trial liability, and cyber for trial data and PHI - and how sponsors catch the gap at CTA review.
Read the full answer →
Question
What cyber and technology E&O insurance does a medical device manufacturer need?
The cyber and technology E&O coverage a medical device manufacturer needs - data breach and PHI/PII liability, ransomware and business interruption, and the connected-device and SaMD exposures that pull technology E&O into the program - and where cyber ends and products liability begins.
Read the full answer →
Question
How much does cyber insurance for a medical device company cost?
What cyber insurance costs for a medical device company, the factors that drive the premium (records held, revenue, connected devices, security controls, claims history), typical ranges by company stage, and the controls that lower it.
Read the full answer →
Question
What is "GMP insurance" and does a pharmaceutical or device manufacturer need it?
What people mean by "GMP insurance" - there is no single policy by that name; it is the insurance program a cGMP-regulated manufacturer (CDMO, API, sterile injectable, device) carries - which coverages actually respond to cGMP-related exposures, and how a 483 or validation loss touches insurance.
Read the full answer →
Question
How much umbrella or excess liability does a medical device company need?
How to size umbrella and excess liability for a medical device company - what the umbrella sits over, what drives the limit (device class, hospital and GPO contracts, distribution scale, sales volume), and how it works alongside dedicated products liability.
Read the full answer →
Question
What insurance does a telehealth or virtual-care company need?
The insurance a telehealth or virtual-care company needs, and why the PC-MSO structure shapes the whole program: telemedicine professional liability for the clinical entity, cyber and technology E&O for the platform and patient data, plus general liability, D&O, and workers compensation - and how partner, payor, and pharmacy contracts drive the limits.
Read the full answer →
Question
How does insurance work in a PC-MSO (friendly-PC) telehealth structure?
How insurance is structured in a PC-MSO (friendly-PC) telehealth model: the physician-owned professional corporation carries the clinical malpractice exposure, the management-services organization carries the platform cyber and technology E&O, and the two entities name each other as additional insured to close the gap between them.
Read the full answer →
Question
What is telemedicine professional liability insurance and how is it rated?
What telemedicine professional liability (medical malpractice) insurance covers for a virtual-care practice, why it is written at the entity level to cover vicarious liability for a fluid clinician network, how it is rated on patient volume or revenue rather than physician headcount, and how multistate licensing and prescribing scope drive the underwriting.
Read the full answer →
Question
What cyber and technology E&O insurance does a telehealth platform need?
Why a telehealth platform needs both cyber liability and technology E&O - cyber for the breach of patient data (PHI) it holds under HIPAA, technology E&O for a failure of the platform software or connectivity - how the two interact with the clinical malpractice policy, and what drives the limits.
Read the full answer →
Question
What insurance does a GLP-1 telehealth weight-loss company need?
The insurance a GLP-1 telehealth weight-loss company needs - telemedicine professional liability for the prescribing clinicians, cyber and technology E&O for the platform, structured across the PC-MSO - why GLP-1 prescribing is a high-scrutiny underwriting factor, and how the products and pharmacy exposure sits with the fulfillment pharmacies when the company does not dispense.
Read the full answer →
Question
What insurance does a cell and gene therapy company need?
The insurance a cell and gene therapy (CGT) company needs and why it is more demanding than a typical biotech program: clinical trial liability at the highest limits, a very long claims tail driven by FDA long-term-follow-up requirements, high-severity products liability, distinctive manufacturing exposures (viral vector, autologous batch loss, cryogenic chain of identity), and D&O sized to the valuation and safety-event scrutiny.
Read the full answer →
Question
How much clinical trial insurance does a gene therapy trial need?
Why gene therapy clinical trials require the highest clinical trial liability limits - irreversible intervention, novel mechanism, rare-disease and pediatric populations - typical limit ranges, per-subject sub-limits, and why the long claims tail from FDA long-term follow-up makes the coverage form as important as the limit.
Read the full answer →
Question
How does FDA long-term follow-up (up to 15 years) affect a gene therapy company's insurance?
Why FDA long-term follow-up of up to 15 years for gene therapy creates a very long claims tail, how it interacts with claims-made coverage, retroactive dates, and extended reporting periods (tail), and why the tail budget should be planned from the start rather than discovered at trial close-out.
Read the full answer →
Question
What does products liability insurance look like for a commercial cell or gene therapy?
How products liability works for a commercialized cell or gene therapy - why the high severity and irreversibility of the intervention, the small treated populations, and the long tail shape the limits and form - and how it coordinates with the clinical trial liability that preceded it.
Read the full answer →
Question
What insurance does cell and gene therapy manufacturing need?
Why cell and gene therapy manufacturing carries exposures a standard biologic does not - viral-vector production, autologous patient-specific batches that cannot be remade, cryogenic cold chain, and chain-of-identity requirements - and the property, cargo, products, and professional coverage that responds.
Read the full answer →
Question
What insurance does a nutraceutical or dietary supplement company need?
The insurance a dietary supplement or nutraceutical company needs - products liability as the core line, label-claim and advertising liability, product recall, general liability and property, and cyber - and why the supplement products exposure and DSHEA/FTC claims environment drive the program.
Read the full answer →
Question
What does products liability insurance for dietary supplements cover?
What products liability covers for a dietary supplement company - adverse reactions, contamination, adulteration, and undeclared ingredients - and why supplement products exposure is placed through specialty markets.
Read the full answer →
Question
What is label-claim and advertising liability for a supplement company?
Why the claims a dietary supplement makes create a distinct liability - structure-function vs disease claims under DSHEA, FTC advertising substantiation, and Proposition 65 - separate from the bodily-injury products exposure.
Read the full answer →
Question
Does a supplement company need contamination and product recall insurance?
Why dietary supplement companies need product recall coverage for contamination, adulteration, and undeclared ingredients, and what recall coverage funds beyond the products liability policy.
Read the full answer →
Question
What insurance does a dietary supplement contract manufacturer need?
The insurance a supplement contract manufacturer or private-label producer needs - products and completed operations, cGMP-oriented property, recall, and professional liability - plus the additional-insured and contract requirements brands and retailers impose.
Read the full answer →
Question
What does biotech products liability insurance cover? (Coverage scope explained)
The coverage scope of biotech and biopharma products liability insurance - third-party bodily injury and property damage from a marketed drug or biologic, the manufacturing-defect / design-defect / failure-to-warn theories it responds to, where it starts and stops relative to clinical trial liability and recall, and the occurrence vs claims-made distinction that governs the long claims tail.
Read the full answer →
Question
What does pathologist malpractice insurance cost and cover?
What pathologist malpractice insurance covers and what drives its cost - medical professional liability for anatomic and clinical pathologists, why anatomic pathology carries some of the highest diagnostic-claim severity in medicine, how subspecialty and volume drive pricing, and how an individual pathologist policy differs from the professional liability a pathology group or diagnostic lab entity needs.
Read the full answer →
Question
What is the difference between D&O and E&O insurance?
The difference between D&O and E&O insurance explained - D&O (directors and officers liability) covers claims about how the company is governed and managed, while E&O (errors and omissions, or professional liability) covers claims about the professional work or services the company delivers. Why the two are separate, how they apply to life sciences companies, and why product companies also need a third line, products liability.
Read the full answer →
Question
What are the requirements for clinical trial liability insurance?
Who requires clinical trial liability insurance and what they mandate - there is no single US federal insurance mandate, so the requirements come from the sponsor CTA/MSA, the research institution and its IRB, and, outside the US, direct regulatory mandates such as EU Clinical Trials Regulation 536/2014. What limits, additional-insured status, indemnification, and subject-injury compensation those parties typically require, and how the requirements scale by trial phase and geography.
Read the full answer →
Question
How does the claims process work for life sciences insurance, and what claims support do you get?
How a life sciences insurance claim moves from first notice through investigation, defense, and resolution - and the claims-advocacy role a specialist broker plays at the moment it matters. Why timely notice protects claims-made coverage, how sponsor additional-insured tenders and the long products-liability tail work, and what ongoing servicing (certificates, annual reviews) keeps a program claim-ready.
Read the full answer →